DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-4,028 Cr | ₹-4,137 Cr | ₹-2,639 Cr | ₹-2,266 Cr | ₹-492 Cr |
What is the latest Cash Flow from Investing Activities ratio of DR REDDYS LABORATORIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-4,028 Cr |
Mar2023 | ₹-4,137 Cr |
Mar2022 | ₹-2,639 Cr |
Mar2021 | ₹-2,266 Cr |
Mar2020 | ₹-492 Cr |
How is Cash Flow from Investing Activities of DR REDDYS LABORATORIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-4,028 Cr | Negative | |
Mar2023 | ₹-4,137 Cr | Negative | |
Mar2022 | ₹-2,639 Cr | Negative | |
Mar2021 | ₹-2,266 Cr | Negative | |
Mar2020 | ₹-492 Cr | - |
Compare Cash Flow from Investing Activities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹112,649.2 Cr | 7.8% | 12.9% | 13.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,068.0 Cr | 1.4% | 0.1% | 13.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,105.0 Cr | 0.8% | 12.3% | 47.2% | Stock Analytics | |
CIPLA | ₹122,016.0 Cr | 2.6% | -0.1% | 0.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,942.0 Cr | 2.7% | -0.6% | 14.4% | Stock Analytics | |
MANKIND PHARMA | ₹98,130.4 Cr | 1.3% | -4.8% | 9.3% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 7.8% |
12.9% |
13.3% |
SENSEX | 2.1% |
3.7% |
14.3% |
You may also like the below Video Courses